| Year |
Citation |
Score |
| 2023 |
Chi D, Chen AD, Lin SJ. Reply to Comment on "Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions". Plastic and Reconstructive Surgery. Global Open. 11: e5258. PMID 38025632 DOI: 10.1097/GOX.0000000000005258 |
0.408 |
|
| 2023 |
Chi D, Tawaklna K, Anolik R. The Relationship between Obesity and Patient Satisfaction after Autologous Breast Reconstruction Remains Unclear. Journal of the American College of Surgeons. PMID 37162042 DOI: 10.1097/XCS.0000000000000752 |
0.355 |
|
| 2023 |
Chi D, Chen AD, Wu WW, Chattha A, Lee BT, Lin SJ. Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions. Plastic and Reconstructive Surgery. Global Open. 11: e4820. PMID 36761011 DOI: 10.1097/GOX.0000000000004820 |
0.302 |
|
| 2023 |
Keane AM, Keane GC, Skolnick GB, Chi D, Ebersole TD, Myckatyn TM, Tenenbaum MM. Immediate post-mastectomy implant-based breast reconstruction: an outpatient procedure? Plastic and Reconstructive Surgery. PMID 36728530 DOI: 10.1097/PRS.0000000000010156 |
0.421 |
|
| 2021 |
Chi D, Ha AY, Keane G, Myckatyn TM. Discussion: A National Survey to Assess the Population's Perception of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Breast Implant Illness. Plastic and Reconstructive Surgery. 147: 804-805. PMID 33776026 DOI: 10.1097/PRS.0000000000007701 |
0.398 |
|
| 2020 |
Chi D, Chen AD, Ha AY, Yaeger LH, Lee BT. Comparative Effectiveness of Transversus Abdominis Plane Blocks in Abdominally Based Autologous Breast Reconstruction: A Systematic Review and Meta-analysis. Annals of Plastic Surgery. PMID 32960515 DOI: 10.1097/01.Gox.0000584896.17203.0A |
0.404 |
|
| 2020 |
Keane G, Chi D, Ha AY, Myckatyn TM. En Bloc Capsulectomy for Breast Implant Illness: A Social Media Phenomenon? Aesthetic Surgery Journal. PMID 32940709 DOI: 10.1093/asj/sjaa203 |
0.412 |
|
| 2019 |
Chi D, Singhal H, Li L, Xiao T, Liu W, Pun M, Jeselsohn R, He H, Lim E, Vadhi R, Rao P, Long H, Garber J, Brown M. Estrogen receptor signaling is reprogrammed during breast tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. PMID 31110002 DOI: 10.1073/Pnas.1819155116 |
0.767 |
|
| 2018 |
Xiao T, Li W, Wang X, Xu H, Yang J, Wu Q, Huang Y, Geradts J, Jiang P, Fei T, Chi D, Zang C, Liao Q, Rennhack J, Andrechek E, et al. Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 29987050 DOI: 10.1073/Pnas.1722617115 |
0.736 |
|
| 2018 |
Chen AD, Chi D, Wu WW, Egeler SA, Chattha AS, Bucknor A, Lee BT, Lin SJ. The Influence of Connective Tissue Disease in Breast Reconstruction: A National Database Analysis. Annals of Plastic Surgery. PMID 29596085 DOI: 10.1097/Sap.0000000000001387 |
0.437 |
|
| 2017 |
Dreijerink KM, Groner AC, Vos ES, Font-Tello A, Gu L, Chi D, Reyes J, Cook J, Lim E, Lin CY, de Laat W, Rao PK, Long HW, Brown M. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer. Cell Reports. 18: 2359-2372. PMID 28273452 DOI: 10.1016/J.Celrep.2017.02.025 |
0.715 |
|
| 2017 |
Singhal H, Chi D, Lim E, He H, Vadhi R, Rao PK, Long HW, Richardson AL, Garber J, Brown M. Abstract LB-257: Estrogen signaling in mature luminal and luminal progenitor cells of BRCA2 carriers and non-carriers Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-257 |
0.728 |
|
| 2017 |
Chi D, Singhal H, Li L, Long HW, Garber JE, Brown MA. Abstract 3376: Reprogramming the estrogen signaling network is a potential mechanism for human breast tumorigenesis Cancer Research. 77: 3376-3376. DOI: 10.1158/1538-7445.Am2017-3376 |
0.719 |
|
| 2017 |
Bucknor A, Chen AD, Kamali P, Chattha AS, Veldhuisen Cv, Branford OA, Chi D, Wu W, Lee BT, Lin SJ. Abstract: Crowdsourcing the Natural Breast in Ethnically-Diverse Women Plastic and Reconstructive Surgery. Global Open. 5: 83. DOI: 10.1097/01.Gox.0000526282.73031.9C |
0.506 |
|
| 2016 |
Johnson SF, Cruz C, Greifenberg AK, Dust S, Stover DG, Chi D, Primack B, Cao S, Bernhardy AJ, Coulson R, Lazaro JB, Kochupurakkal B, Sun H, Unitt C, Moreau LA, et al. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell Reports. 17: 2367-2381. PMID 27880910 DOI: 10.1016/J.Celrep.2016.10.077 |
0.465 |
|
| 2016 |
Mongan A, Rozenzhak S, Bien G, Chi D, Nishikawa H, Hyland F, Godsey J. Abstract 3941: Novel biomarkers and multiplexed NGS to stratify FFPE NSCLC by tumor infiltrating lymphocytes and histopathology phenotypes Cancer Research. 76: 3941-3941. DOI: 10.1158/1538-7445.Am2016-3941 |
0.356 |
|
| 2014 |
Johnson S, Johnson N, Chi D, Primack B, Cruz C, Stover D, Greifenberg A, Cao S, O'Connor K, Baselga J, Balmaña J, Serra V, Geyer M, D'Andrea A, Lim E, et al. 238 Reversal of primary and acquired PARP-inhibitor resistance in BRCA-mutated triple-negative breast cancers by inhibition of transcriptional cyclin-dependent kinases (CDKs) European Journal of Cancer. 50: 80. DOI: 10.1016/S0959-8049(14)70364-8 |
0.43 |
|
| 2013 |
Buchwalter G, Hickey MM, Cromer A, Selfors LM, Gunawardane RN, Frishman J, Jeselsohn R, Lim E, Chi D, Fu X, Schiff R, Brown M, Brugge JS. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. Cancer Cell. 23: 753-67. PMID 23764000 DOI: 10.1016/J.Ccr.2013.04.026 |
0.761 |
|
| 2013 |
Chi D, He H, Yeung T, Jeselsohn R, Schnitt S, Garber J, Richardson A, Lim E, Brown M. Abstract 2313: Differences in estrogen receptor signaling in normal mammary epithelial cells and ER-positive primary breast tumors and metastases. Cancer Research. 73: 2313-2313. DOI: 10.1158/1538-7445.Am2013-2313 |
0.77 |
|
| 2013 |
Johnson SF, Johnson N, Chi D, Primack B, D'Andrea AD, Lim E, Shapiro GI. Abstract 1788: The CDK inhibitor dinaciclib sensitizes triple-negative breast cancer cells to PARP inhibition. Cancer Research. 73: 1788-1788. DOI: 10.1158/1538-7445.Am2013-1788 |
0.56 |
|
| 2012 |
Lim E, He HH, Chi D, Garber JE, Richardson A, Brown M. Estrogen receptor (ER) signaling in normal, BRCA (B) 1 and B2 mutation associated, and ER-positive breast cancer (BC) mammary cells. Journal of Clinical Oncology. 30: 576-576. DOI: 10.1200/Jco.2012.30.15_Suppl.576 |
0.637 |
|
| 2012 |
Lim E, He H, Chi D, Yeung T, Schnitt S, Liu S, Garber J, Richardson A, Brown M. Abstract PD01-08: Differences in estrogen receptor signaling in non-malignant primary ER-positive breast epithelial cells and breast cancer. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd01-08 |
0.712 |
|
| Show low-probability matches. |